Chad Robins

Chad Robins

Chief Executive Officer at ADAPTIVE BIOTECHNOLOGIES CORPORATION

Net worth: 8 M $ as of 2024-03-30

49 year
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Chad Robins is an Independent Director at CM Life Sciences III, Inc. and a Chairman & Chief Executive Officer at Adaptive Biotechnologies Corp. He is on the Board of Directors at CM Life Sciences III, Inc., Aortica Corp., AdvaMedDx, AltPep Corp. and HeadLight Technologies, Inc. He received his undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-04 2,576,701 ( 1.78% ) 8 M $ 2024-03-30

Chad Robins active positions

CompaniesPositionStart
ADAPTIVE BIOTECHNOLOGIES CORPORATION Chief Executive Officer 2009-09-07
Director/Board Member -
Founder 2013-12-31
Director/Board Member -
Director/Board Member -
Washington Biotechnology & Biomedical Association Director/Board Member 2016-12-31
All active positions of Chad Robins

Former positions of Chad Robins

CompaniesPositionEnd
CEREVEL THERAPEUTICS HOLDINGS, INC. Director/Board Member -
CM LIFE Director/Board Member -
See the detail of Chad Robins's experience

Training of Chad Robins

Cornell University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chad Robins's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ADAPTIVE BIOTECHNOLOGIES CORPORATION

Health Technology

Private companies7

Health Technology

Washington Biotechnology & Biomedical Association

Commercial Services

Technology Services

Commercial Services

Finance

Finance

See company connections